274 related articles for article (PubMed ID: 9550379)
1. In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets.
Cua DJ; Stohlman SA
J Immunol; 1997 Dec; 159(12):5834-40. PubMed ID: 9550379
[TBL] [Abstract][Full Text] [Related]
2. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
Cua DJ; Coffman RL; Stohlman SA
J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
[TBL] [Abstract][Full Text] [Related]
3. Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages.
Duncan DD; Swain SL
Eur J Immunol; 1994 Oct; 24(10):2506-14. PubMed ID: 7925578
[TBL] [Abstract][Full Text] [Related]
4. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
Schweitzer AN; Sharpe AH
J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
[TBL] [Abstract][Full Text] [Related]
5. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction.
Kato T; Hakamada R; Yamane H; Nariuchi H
J Immunol; 1996 May; 156(10):3932-8. PubMed ID: 8621933
[TBL] [Abstract][Full Text] [Related]
6. Negative feedback mechanism suppresses interleukin-12 production by antigen-presenting cells interacting with T helper 2 cells.
Hino A; Nariuchi H
Eur J Immunol; 1996 Mar; 26(3):623-8. PubMed ID: 8605930
[TBL] [Abstract][Full Text] [Related]
7. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
Matsushima GK; Stohlman SA
J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
[TBL] [Abstract][Full Text] [Related]
8. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity.
Alleva DG; Johnson EB; Wilson J; Beller DI; Conlon PJ
J Leukoc Biol; 2001 Mar; 69(3):440-8. PubMed ID: 11261792
[TBL] [Abstract][Full Text] [Related]
9. Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-gamma is essential but insufficient.
van der Veen RC; Dietlin TA; Pen L; Gray JD; Hofman FM
Cell Immunol; 2000 Dec; 206(2):125-35. PubMed ID: 11161444
[TBL] [Abstract][Full Text] [Related]
10. Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses.
Homey B; Assmann T; Vohr HW; Ulrich P; Lauerma AI; Ruzicka T; Lehmann P; Schuppe HC
J Immunol; 1998 Jun; 160(11):5331-40. PubMed ID: 9605132
[TBL] [Abstract][Full Text] [Related]
11. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK
J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
[TBL] [Abstract][Full Text] [Related]
13. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals.
Palmer EM; van Seventer GA
J Immunol; 1997 Mar; 158(6):2654-62. PubMed ID: 9058798
[TBL] [Abstract][Full Text] [Related]
14. Alloantigen-reactive Th1 development in IL-12-deficient mice.
Piccotti JR; Li K; Chan SY; Ferrante J; Magram J; Eichwald EJ; Bishop DK
J Immunol; 1998 Feb; 160(3):1132-8. PubMed ID: 9570526
[TBL] [Abstract][Full Text] [Related]
15. Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo.
Bradley LM; Harbertson J; Biederman E; Zhang Y; Bradley SM; Linton PJ
Eur J Immunol; 2002 Aug; 32(8):2338-46. PubMed ID: 12209647
[TBL] [Abstract][Full Text] [Related]
16. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
Feili-Hariri M; Falkner DH; Morel PA
J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of IFN-alpha on the expression of various TH2 cytokines in human CD4+ T cells.
Shibuya H; Hirohata S
J Allergy Clin Immunol; 2005 Jul; 116(1):205-12. PubMed ID: 15990796
[TBL] [Abstract][Full Text] [Related]
18. Effective stimulation for IL-12 p35 mRNA accumulation and bioactive IL-12 production of antigen-presenting cells interacted with Th cells.
Yamane H; Kato T; Nariuchi H
J Immunol; 1999 Jun; 162(11):6433-41. PubMed ID: 10352257
[TBL] [Abstract][Full Text] [Related]
19. Regulatory role of pro-Th1 and pro-Th2 cytokines in modulating the activity of Th1 and Th2 cells when B cell and macrophages are used as antigen presenting cells.
Singh V; Agrewala JN
BMC Immunol; 2006 Aug; 7():17. PubMed ID: 16889674
[TBL] [Abstract][Full Text] [Related]
20. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
